Department of Radiation Medicine, Georgetown University School of Medicine, Washington, D.C, USA.
Department of Physiology, Biophysics and Systems Biology and the WorldQuant Initiative, Weill Cornell Medicine, New York, NY, USA.
Nat Commun. 2024 Jun 11;15(1):4825. doi: 10.1038/s41467-024-48920-y.
Our previous research revealed a key microRNA signature that is associated with spaceflight that can be used as a biomarker and to develop countermeasure treatments to mitigate the damage caused by space radiation. Here, we expand on this work to determine the biological factors rescued by the countermeasure treatment. We performed RNA-sequencing and transcriptomic analysis on 3D microvessel cell cultures exposed to simulated deep space radiation (0.5 Gy of Galactic Cosmic Radiation) with and without the antagonists to three microRNAs: miR-16-5p, miR-125b-5p, and let-7a-5p (i.e., antagomirs). Significant reduction of inflammation and DNA double strand breaks (DSBs) activity and rescue of mitochondria functions are observed after antagomir treatment. Using data from astronaut participants in the NASA Twin Study, Inspiration4, and JAXA missions, we reveal the genes and pathways implicated in the action of these antagomirs are altered in humans. Our findings indicate a countermeasure strategy that can potentially be utilized by astronauts in spaceflight missions to mitigate space radiation damage.
我们之前的研究揭示了一个与太空飞行相关的关键 microRNA 特征,可以作为生物标志物,并开发对策治疗来减轻空间辐射造成的损伤。在这里,我们扩展了这项工作,以确定对策治疗所挽救的生物因素。我们对暴露于模拟深空辐射(0.5Gy 银河宇宙辐射)的 3D 微血管细胞培养物进行了 RNA 测序和转录组分析,同时使用和不使用三种 microRNA 的拮抗剂:miR-16-5p、miR-125b-5p 和 let-7a-5p(即 antagomirs)。在 antagomir 处理后,观察到炎症和 DNA 双链断裂(DSBs)活性显著减少,线粒体功能得到恢复。利用来自 NASA 双胞胎研究、Inspiration4 和 JAXA 任务的宇航员参与者的数据,我们揭示了这些 antagomirs 作用所涉及的基因和途径在人类中发生了改变。我们的研究结果表明,一种对策策略可能被太空飞行任务中的宇航员用于减轻空间辐射损伤。
Nat Commun. 2024-6-11
Life Sci Space Res (Amst). 2020-8
Naturwissenschaften. 2007-7
Life Sci Space Res (Amst). 2015-7-17
Int J Mol Sci. 2025-2-18
Clin Kidney J. 2024-10-29
Nucleic Acids Res. 2025-1-6
Life Sci Alliance. 2024-2
Signal Transduct Target Ther. 2023-11-10
J Dev Biol. 2023-6-13
Nucleic Acids Res. 2023-1-6
Front Cell Dev Biol. 2022-4-19